Alira Health

Regulatory: MedTech

FDA Meeting Preparation and Representation

Our services: FDA meetings.

As part of our regulatory services in pharma, the Alira Health team can:
  • Prepare and submit meeting request and packages to FDA for various Type A, Type B (Pre-IND and End-of-Phase Meetings) and Type C meetings with the FDA and analyze FDA responses
  • Represent the sponsor at FDA meetings and in other correspondences with the FDA
  • Advise our clients on regulatory options and potential pathways
  • Conduct mock FDA meetings to prepare clients for FDA meetings

Why choose Alira Health?

As your partner, Alira Health supports your innovation, optimizing product development success every step of the way. Our integrated, collaborative teams provide a lifecycle approach to delivering our services, including:

  • Regulatory strategy
  • Regulatory intelligence
  • Regulatory operations
  • Clinical
  • Market access

Explore our related publications.

Articles August 19, 2026
How to Develop Global Clinical Evidence Strategies for Regulatory Success in Medtech
Discover how a strategically planned clinical evidence generation strategy can support global device approval, maximize evidence value, and prepare for international expansion.
MedTech Regulatory
Articles July 21, 2026
Preparing Rare Disease Manufacturers for JCA: The Role of Early Stakeholder Engagement
Discover how stakeholder engagement helps rare disease manufacturers prepare for JCA and how to apply stakeholder management best practices in the JCA context.
Healthcare Technology Rare Disease Regulatory
Case Studies June 16, 2026
Infection Control and Prevention Company Defines Winning US Market Entry Strategy
Discover how an infection prevention company defined a successful US market entry strategy amid regulatory uncertainty for novel wound care disinfectant products.
Infection Prevention Regulatory
Articles June 4, 2026
Patient Involvement Under EU HTA: What JSC and JCA Mean for Pharma, Biotech, and Medtech Companies
Learn where patient involvement fits within JSC and JCA under EU HTA Regulation and how to prepare your engagement strategy.
EU Healthcare Technology Regulatory
Articles April 24, 2026
From Approval to Adoption: A New Framework for Medtech Success
Medtech success requires more than approval. Discover how aligning evidence, patient needs, and market access drives adoption.
Interview MedTech Regulatory
Events April 21, 2026
MedTech World North America 2026
Meet us onsite to discover how our integrated model reduces rework, accelerates time to adoption, and improves the likelihood of achieving both coverage and commercial scale.
Regulatory USA
Articles November 20, 2025
Why SEND Matters: Streamlining Nonclinical Data Submissions for Regulatory Success
Discover why SEND compliance is essential for your regulatory submission submissions, and how Alira Health helps sponsors ensure data quality and regulatory success.
CDISC Interview Regulatory
Welcome to Alira Health. This site is best viewed in Chrome, Microsoft Edge, or Firefox.